Geode Capital Management’s Livent Corporation LTHM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,921,244
| Closed | -$70.5M | – | 4723 |
|
|
2023
Q4 | $70.5M | Buy |
3,921,244
+279,443
| +8% | +$4.35M | 0.01% | 1100 |
|
|
2023
Q3 | $67.1M | Buy |
3,641,801
+136,071
| +4% | +$3.11M | 0.01% | 1024 |
|
|
2023
Q2 | $96.2M | Buy |
3,505,730
+288,004
| +9% | +$6.91M | 0.01% | 811 |
|
|
2023
Q1 | $69.9M | Buy |
3,217,726
+152,007
| +5% | +$3.51M | 0.01% | 962 |
|
|
2022
Q4 | $60.9M | Buy |
3,065,719
+111,215
| +4% | +$3.04M | 0.01% | 1013 |
|
|
2022
Q3 | $90.6M | Buy |
2,954,504
+201,704
| +7% | +$5.65M | 0.01% | 721 |
|
|
2022
Q2 | $62.5M | Sell |
2,752,800
-29,982
| -1% | -$772K | 0.01% | 953 |
|
|
2022
Q1 | $72.5M | Buy |
2,782,782
+89,693
| +3% | +$2.09M | 0.01% | 976 |
|
|
2021
Q4 | $65.7M | Buy |
2,693,089
+93,089
| +4% | +$2.53M | 0.01% | 1105 |
|
|
2021
Q3 | $60.1M | Buy |
2,600,000
+101,819
| +4% | +$2.28M | 0.01% | 1124 |
|
|
2021
Q2 | $48.4M | Buy |
2,498,181
+136,956
| +6% | +$2.49M | 0.01% | 1335 |
|
|
2021
Q1 | $40.9M | Buy |
2,361,225
+182,989
| +8% | +$3.59M | 0.01% | 1388 |
|
|
2020
Q4 | $41M | Buy |
2,178,236
+132,599
| +6% | +$1.85M | 0.01% | 1247 |
|
|
2020
Q3 | $18.3M | Sell |
2,045,637
-58,864
| -3% | -$443K | ﹤0.01% | 1600 |
|
|
2020
Q2 | $13M | Buy |
2,104,501
+56,191
| +3% | +$354K | ﹤0.01% | 1778 |
|
|
2020
Q1 | $10.8M | Buy |
2,048,310
+136,714
| +7% | +$1.15M | ﹤0.01% | 1697 |
|
|
2019
Q4 | $16.3M | Buy |
1,911,596
+73,154
| +4% | +$560K | ﹤0.01% | 1691 |
|
|
2019
Q3 | $12.3M | Sell |
1,838,442
-65,810
| -3% | -$442K | ﹤0.01% | 1797 |
|
|
2019
Q2 | $13.2M | Buy |
1,904,252
+243,006
| +15% | +$2.18M | ﹤0.01% | 1750 |
|
|
2019
Q1 | $20.4M | Buy |
1,661,246
+1,390,391
| +513% | +$18.1M | 0.01% | 1408 |
|
|
2018
Q4 | $3.74M | Buy |
+270,855
| New | +$4.42M | ﹤0.01% | 2401 |
|
Other funds holding LTHM
MIM
WAM
MLICM
AAG
ACA